Clinical Trial Update: Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a triple combination of navitoclax, venetoclax, and decitabine for advanced myeloid neoplasms. The study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelofibrosis
• Myeloproliferative Neoplasm

Drugs mentioned

• Decitabine (Decitabine)
• Navitoclax (navitoclax)
• Venetoclax (venetoclax)

Snippet

Sponsor: Jacqueline Garcia, MD | Conditions: Myeloid Malignancy, Myelodysplastic Syndromes | Phase 1 | Status: ACTIVE_NOT_RECRUITING